Axsome Therapeutics AXSM Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's finance lease liabilities?
- Axsome Therapeutics (AXSM) reported finance lease liabilities of $5.84M in Q1 2026.
- How has Axsome Therapeutics's finance lease liabilities changed year-over-year?
- Axsome Therapeutics's finance lease liabilities increased by 58.8% year-over-year, from $3.68M to $5.84M.
- What does finance lease liabilities mean?
- Debt-like obligations arising from long-term equipment or property leases.
- How do you interpret finance lease liabilities?
- Higher values indicate greater reliance on leased capital assets, which increases financial leverage.
- How does finance lease liabilities compare across companies?
- Comparable to other debt metrics in capital-intensive sectors.